ClassID:

94283

C07D215/46 - CPC Classification

Classification description:

Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms

Recent Application in this class:
#1
20250115579
2025-04-10

QUINOLINE cGAS ANTAGONIST COMPOUNDS

#2
20250084063
2025-03-13

BICYCLIC HETEROCYCLES AS MRGPRX2 ANTAGONISTS

#3
20250059218
2025-02-20

ENPP1 Inhibitors and Methods of Modulating Immune Response

#4
20250034139
2025-01-30

AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY

#5
20240398761
2024-12-05

Use of Chloroquine Compounds for Treatment of Inflammatory Conditions

#6
20240383893
2024-11-21

Hydroxamic Acid Compound Having ENPP1 Inhibitory Activity and Use Thereof

#7
20240382474
2024-11-21

ENPP1 MODULATORS AND USES THEREOF

#8
20240360149
2024-10-31

COMPOUND WITH ANTICANCER ACTIVITY

#9
20240352028
2024-10-24

SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C

#10
20240343716
2024-10-17

COMPOUNDS FOR PREVENTING, INHIBITING, OR TREATING CANCER, AIDS AND/OR PREMATURE AGING

#11
20240336570
2024-10-10

Modulators of mas-related g-protein receptor X2 and related products and methods

#12
20240270717
2024-08-15

COMPOUNDS AND METHODS FOR TARGETING PATHOGENIC BLOOD VESSELS

#13
20240262793
2024-08-08

QUINAZOLINE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#14
20240246941
2024-07-25

SUBSTITUTED 4-(3-AMINOPROP-1-YL)AMINOQUINOLINE ANALOGS AS MODULATORS OF MELANOMA-ASSOCIATED ANTIGEN 11 UBIQUITIN LIGASE

#15
20240182423
2024-06-06

4-AMINOQUINOLINES FOR TREATMENT OF MULTIDRUG RESISTANT MALARIA

#16
20240092760
2024-03-21

Quinoline cGAS antagonist compounds

#17
20240043441
2024-02-08

INHIBITORS OF KRAS G12C

#18
20230416786
2023-12-28

USE OF AMINOQUINOLINE COMPOUNDS FOR HIGHER GENE INTEGRATION

#19
20230312499
2023-10-05

Carbamate compounds and methods of making and using same

#20
20230303586
2023-09-28

INHIBITORS OF KRAS G12C

#21
20230219927
2023-07-13

AKT3 MODULATORS

#22
20230212183
2023-07-06

Substituted piperazines as inhibitors of KRAS G12C

#23
20230159554
2023-05-25

Compound with anticancer activity

#24
20230081291
2023-03-16

Quinoline cGAS antagonist compounds

#25
20230065217
2023-03-02

Modulators of Mas-related G-protein receptor X2 and related products and methods

#26
20230040299
2023-02-09

2,3-DISUBSTITUTED 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS

#27
20230022696
2023-01-26

SMALL MOLECULE INHIBITORS OF AUTOPHAGY AND HISTONE DEACTYLASES AND USES THEREOF

#28
20220388962
2022-12-08

MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED DISORDERS

#29
20220332685
2022-10-20

COMPOUND DERIVED FROM QUINOLINE, USE OF A COMPOUND, COMPOSITION AND METHOD FOR THE TREATMENT OR PROPHYLAXIS OF A CONDITION CAUSED BY A BLOOD PARASITE

#30
20220289775
2022-09-15

ENPP1 Inhibitors and Methods of Modulating Immune Response

#31
20220242875
2022-08-04

INHIBITORS OF KRAS G12C

#32
20220204452
2022-06-30

ANTIMALARIAL COMPOUNDS

#33
20220144822
2022-05-12

PROCESS FOR THE PREPARATION OF A SUBSTITUTED IMIDAZOQUINOLINE

#34
20220143508
2022-05-12

METHOD AND SYSTEM FOR DEPLOYING STANDALONE AND REACTIVE SQUARES GAMES ADAPTED WITH FANTASY SPORTS AND PREDICTIVE ELEMENTS

#35
20220127253
2022-04-28

COMPOUNDS FOR PREVENTING, INHIBITING, OR TREATING CANCER, AIDS AND/OR PREMATURE AGING

#36
20220064118
2022-03-03

Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy

#37
20210323925
2021-10-21

Crystals of hydroxychloroquine sulfate

#38
20210253530
2021-08-19

C-met modulators and methods of use

#39
20210206723
2021-07-08

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

#40
20210188869
2021-06-24

Substituted quinazolines as inhibitors of KRAS G12C

#41
20210188793
2021-06-24

Carbamate compounds and methods of making and using same

#42
20210188777
2021-06-24

Tetrahydroquinoline-based bromodomain inhibitors

#43
20210163476
2021-06-03

Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity

#44
20210147385
2021-05-20

Compounds and methods for targeting pathogenic blood vessels

#45
20210061784
2021-03-04

Composition and methods for inhibiting mammalian sterile 20-like kinase 1

#46
20210052553
2021-02-25

Use of clemizole compounds for treatment of inflammatory conditions

#47
20210046073
2021-02-18

2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors

#48
20210024540
2021-01-28

Compound with anticancer activity

#49
20200407321
2020-12-31

High-yielding continuous flow synthesis of antimalarial drug hydroxychloroquine

#50
20200331860
2020-10-22

C-Met Modulators and Methods of Use

#51
20200290977
2020-09-17

Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof

#52
20200270223
2020-08-27

Carbamate compounds and methods of making and using same

#53
20200222807
2020-07-16

METHOD AND SYSTEM FOR DEPLOYMENT OF STANDALONE AND REACTIVE SQUARES GAMES ADAPTED FOR EMPLOYMENT IN A FANTASY SPORTS LEAGUE ENVIRONMENT

#54
20200172525
2020-06-04

Compounds and pharmaceutical compositions containing at least one of the compounds

#55
20200102321
2020-04-02

Substituted cinnolines as inhibitors of KRAS G12C

#56
20200095204
2020-03-26

Multifunctional aminoquinoline therapeutic agents

#57
20200079739
2020-03-12

Tetrahydroquinoline-based bromodomain inhibitors

#58
20200071272
2020-03-05

Bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use

#59
20200062728
2020-02-27

Quinoline-based compounds and methods of inhibiting CDK8/19

#60
20190322656
2019-10-24

Compound, and production method thereof, and methods of treatment using the compound

#61
20190248747
2019-08-15

Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy

#62
20190194193
2019-06-27

Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity

#63
20190169163
2019-06-06

Quinoline derivative and use thereof

#64
20190144417
2019-05-16

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

#65
20190127329
2019-05-02

Inhibitors for the treatment of cancer and related methods

#66
20190092731
2019-03-28

Multifunctional aminoquinoline therapeutic agent

#67
20190062278
2019-02-28

Analogues of hydroxychloroquine (HCQ) without retinal toxicity

#68
20190054118
2019-02-21

Small Molecule Agonists and Antagonists of NR2F6 Activity in Animals

#69
20180362497
2018-12-20

Composition and methods for inhibiting mammalian sterile 20-like kinase 1

#70
20180339981
2018-11-29

Compounds for preventing, inhibiting, or treating cancer, aids and/or premature aging

#71
20180303831
2018-10-25

2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors

#72
20180298000
2018-10-18

AMINOQUINOLINE COMPOUNDS HAVING ANTICANCER ACTIVITY

#73
20180208568
2018-07-26

CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME

#74
20180200228
2018-07-19

Use of chloroquine and clemizole compounds for treatment of inflammatory and cancerous conditions

#75
20180194748
2018-07-12

Substituted quinazoline compounds and methods of use thereof

#76
20180118757
2018-05-03

Substituted quinolines as inhibitors of KRAS G12C

#77
20180009760
2018-01-11

Compounds, compositions and associated methods comprising 3-aryl quinolines

#78
20170355678
2017-12-14

C-met modulators and methods of use

#79
20170275252
2017-09-28

Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy

#80
20170247340
2017-08-31

Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof

#81
20170190711
2017-07-06

Urea and amide derivatives of aminoalkylpiperazines and use thereof

#82
20170166530
2017-06-15

Bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use

#83
20170073320
2017-03-16

Carbamate compounds and methods of making and using same

#84
20170022184
2017-01-26

Substituted quinazoline compounds and methods of use thereof

#85
20170000801
2017-01-05

Triarylmethane analogs and their use in treating cancers

#86
20160346673
2016-12-01

Method and system for deployment of standalone and reactive squares games adapted for employment in a fantasy sports league environment

#87
20160340313
2016-11-24

COMPOUNDS, COMPOSITIONS AND ASSOCIATED METHODS COMPRISING 3-ARYL QUINOLINES

#88
20160340312
2016-11-24

Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors

#89
20160168099
2016-06-16

NOVEL BISAMINOQUINOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS PREPARED THEREFROM AND THEIR USE

#90
20160016908
2016-01-21

2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors

#91
20150376133
2015-12-31

C-Met Modulators and Methods of Use

#92
20150376132
2015-12-31

Quinoline sulfonyl derivatives and uses thereof

#93
20150361077
2015-12-17

Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity

#94
20150336897
2015-11-26

Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors

#95
20150307478
2015-10-29

Compounds useful for treating AIDS

#96
20150299129
2015-10-22

Compounds for treating cancer

#97
20150274724
2015-10-01

Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors

#98
20150239900
2015-08-27

Substituted quinazolines as inhibitors of KRAS G12C

#99
20150203491
2015-07-23

Imidazo[4,5-C]quinolines as DNA-PK inhibitors

#100
20150168374
2015-06-18

Senescence tracers

#101
20140364424
2014-12-11

Sulfonaminoquinoline hepcidin antagonists

#102
20140350048
2014-11-27

Compounds, compositions and associated methods comprising 3-aryl quinolines

#103
20140288120
2014-09-25

Compounds useful for treating aids

#104
20140249144
2014-09-04

Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient

#105
20140200346
2014-07-17

Process for the synthesis of 7-chloro-4-(piperazin-1-yl)-quinoline

#106
20140155432
2014-06-05

Activators and therapeutic applications thereof

#107
20140094465
2014-04-03

Compounds as S-Nitrosoglutathione Reductase Inhibitors

#108
20140080831
2014-03-20

Compounds useful for treating cancer

#109
20130310348
2013-11-21

Quinoline derivatives and uses thereof

#110
20130217671
2013-08-22

Quinoline derivatives and MELK inhibitors containing the same

#111
20130196993
2013-08-01

N-heteroaryl compounds

#112
20130172337
2013-07-04

Imidazo[4,5-c]quinolines as DNA-PK inhibitors

#113
20130158067
2013-06-20

TRPV1 antagonists

#114
20130085159
2013-04-04

Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine

#115
20130030180
2013-01-31

Methods of facilitating neural cell survival using GDNF family ligand (GFL) mimetics or RET signaling pathway activators

#116
20120329796
2012-12-27

COMPOUNDS USEFUL FOR TREATING PREMATURE AGING AND IN PARTICULAR PROGERIA

#117
20120329786
2012-12-27

COMPOUNDS AND THERAPEUTIC USES THEREOF

#118
20120283265
2012-11-08

Compounds useful for treating AIDS

#119
20120283256
2012-11-08

Heterocycle compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the APP metabolism occurs

#120
20120277230
2012-11-01

COMPOUNDS USEFUL FOR TREATING CANCER

#121
20120251616
2012-10-04

Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof

#122
20120214803
2012-08-23

Novel Sulfonaminoquinoline Hepcidin Antagonists

#123
20120190847
2012-07-26

Triarylmethane analogs and their use in treating cancers

#124
20120184523
2012-07-19

C-Met Modulators and Method of Use

#125
20120172376
2012-07-05

Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors

#126
20120129887
2012-05-24

COMPOUNDS DERIVED FROM ARTESUNATE, PREPARATION PROCESS, PHARMACEUTICAL COMPOSITION AND USE OF THE RESPECTIVE MEDICINE

#127
20120108815
2012-05-03

Bifunctional/polyfunctional dopamine D2/D3 agonist as neuroprotective agents for treatment of neurodegenerative diseases

#128
20120094977
2012-04-19

Compositions and methods for the treatment of disease associated with TRP-P8 expression

#129
20120022065
2012-01-26

C-met modulators and method of use

#130
20120004197
2012-01-05

Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient

#131
20110281844
2011-11-17

NON-IMIDAZOLE ALKYLAMINES AS HISTAMINE H3-RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS

#132
20110263628
2011-10-27

N-hydroxyamide derivatives and use thereof

#133
20110257160
2011-10-20

Quinoline derivatives and uses thereof

#134
20110251210
2011-10-13

Modified chloroquines with single ring moiety or fused ring moiety

#135
20110251209
2011-10-13

Compounds for treating parasitic disease

#136
20110086861
2011-04-14

Pharmaceutical compositions and methods for the treatment of cancer

#137
20110077233
2011-03-31

C-Met Modulators and Method of Use

#138
20100303899
2010-12-02

Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof

#139
20100222346
2010-09-02

4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy

#140
20100189762
2010-07-29

TRIARYLMETHANE ANALOGS AND THEIR USE IN TREATING CANCERS

#141
20100179155
2010-07-15

Activators and therapeutic applications thereof

#142
20100160296
2010-06-24

Use of imipramine blue and analogs thereof in treating cancers

#143
20100145056
2010-06-10

ACETYL 2-HYDROXY-1,3-DIAMINOALKANES

#144
20100137329
2010-06-03

Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme

#145
20100075953
2010-03-25

SUBSTITUTED PIPERAZINES, (1,4) DIAZEPINES, AND 2,5-DIAZABICYCLO (2.2.1) HEPTANES AS HISTAMINE H1 AND/OR H3 ANTAGONISTS OR HISTAMINE H3 REVERSE ANTAGONISTS

#146
20090270371
2009-10-29

QUINOLINE DERIVATIVES USEFUL IN THE TREATMENT OF MGLUR5 RECEPTOR-MEDIATED DISORDERS

#147
20090247519
2009-10-01

AMINO-ETHYL-AMINO-ARYL (AEAA) COMPOUNDS AND THEIR USE

#148
20090215730
2009-08-27

Antineoplastic compounds and pharmaceutical compositions thereof

#149
20090176745
2009-07-09

TRIARYLMETHANE ANALOGS AND THEIR USE IN TREATING CANCERS

#150
20090170896
2009-07-02

c-Met modulators and methods of use

#151
20090105299
2009-04-23

c-Met modulators and methods of use

#152
20080249139
2008-10-09

Benzamide 2-hydroxy-3-diaminoalkanes

#153
20080188462
2008-08-07

Quinoline derivatives and uses thereof

#154
20080161349
2008-07-03

Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof

#155
20080139551
2008-06-12

TUMOR NECROSIS FACTOR ALPHA INHIBITORS AND THEIR USE IN THE TREATMENT OF HUMAN DISEASES

#156
20080119514
2008-05-22

Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof

#157
20080045546
2008-02-21

Tetradydro-Naphthalene And Urea Derivatives

#158
20080021028
2008-01-24

N-hydroxyamide derivatives and use thereof

#159
20070293483
2007-12-20

Acetyl 2-hydroxy-1, 3-diaminoalkanes

#160
20070281968
2007-12-06

Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine

#161
20070244116
2007-10-18

c-Met modulators and method of use

#162
20070244103
2007-10-18

Novel Compounds Having an Anti-Bacterial Activity

#163
20070225307
2007-09-27

c-Met modulators and method of use

#164
20070197509
2007-08-23

Compositions and methods for modulating gated ion channels

#165
20070099950
2007-05-03

Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain

#166
20070099919
2007-05-03

Composition and synthesis of new reagents for inhibition of HIV replication

#167
20070054928
2007-03-08

c-Met modulators and methods of use

#168
20060293310
2006-12-28

Derivatives of 1-piperazine-and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme

#169
20060247223
2006-11-02

Non-imidazole alkylamines as histamine H- receptor ligands and their therapeutic applications

#170
20060142335
2006-06-29

Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors

#171
20060052597
2006-03-09

Aryloxyalkylamine derivatives as h3 receptor ligands

#172
20060025404
2006-02-02

Substituted piperazines,(1,4) diazepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists

#173
20050267199
2005-12-01

2-amino- and 2-thio- substituted 1,3-diaminopropanes

#174
20050124626
2005-06-09

Novel compounds

#175
20050070573
2005-03-31

Aminoquinoline compounds

#176
20050054651
2005-03-10

Compositions and methods for the treatment of disease associated with Trp-p8 expression

#177
20050032848
2005-02-10

Benzamide 2-hydroxy-3-diaminoalkanes

#178
20050026947
2005-02-03

1H-imidazo dimers